Cardiomegaly clinical trials
The registry lists 21 studies for Cardiomegaly across 8 countries. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-28.
Keep track of what changes. Save the Cardiomegaly studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWho runs them
Carebot s.r.o. (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Indiana University (1) · Children's National Research Institute (1) · Oxford University Hospitals NHS Trust (1) · Rainer Oberbauer (1) · Universitas Sumatera Utara (1) · Medical University of Warsaw (1)
Who these studies take
Of the 6 Cardiomegaly studies recruiting now, 2 (33%) set no upper age limit and 4 (67%) stop at 75 or younger. 3 (50%) take children under 18. 1 (17%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (33%) | 2 (33%) |
| 18 | 5 (83%) | 5 (83%) |
| 30 | 5 (83%) | 4 (67%) |
| 40 | 5 (83%) | 4 (67%) |
| 50 | 4 (67%) | 4 (67%) |
| 65 | 3 (50%) | 3 (50%) |
| 75 | 3 (50%) | 3 (50%) |
| 85 | 2 (33%) | 2 (33%) |
Across all 21 studies, recruiting or not: 48% stop at 75 or younger and 33% at 65; 43% take children; 5% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's AtaxiaRecruitingNCT05302271Phase 11 country
- Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna TrialRecruitingNCT06686251Not applicable1 country
- Pediatric Cardiomyopathy Mutation AnalysisRecruitingNCT024320921 country
- Fish Oil, Metformin and Heart Health in PCOSRecruitingNCT06424860Phase 11 country
- Sodium Glucose Co-Transporter 2 (SGLT2) and STEMIRecruitingNCT05305911Phase 21 country
- MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathiesRecruitingNCT06555237Phase 21 country
- Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac HypertrophyWithdrawnNCT05953831Phase 2
- Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical PracticeCompletedNCT059639451 country
- MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy PatientsCompletedNCT038224421 country
- The Association Between Anemia and CardiomegalyCompletedNCT058162781 country
- AI Assisted Detection of Chest X-RaysCompletedNCT060758361 country
- Cardiac Allograft Remodeling and Effects of SirolimusTerminatedNCT01889992Phase 11 country
- Retrospective Study of Carebot AI CXR Performance in Preclinical PracticeCompletedNCT055944851 country
- Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading LesionsCompletedNCT025457901 country
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic CardiomyopathyWithdrawnNCT01556568Phase 22 countries
- Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis PatientsCompletedNCT03182699Phase 41 country
- Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive SubjectsCompletedNCT03089333Phase 41 country
- Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD)Status unknownNCT01323712Phase 2/31 country
- Study of Oral PG-116800 Following a Heart AttackCompletedNCT00067236Phase 23 countries
- Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)CompletedNCT00001965Phase 21 country
- Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged HeartsCompletedNCT000018781 country